Lucia Altucci Selected Research

Thrombosis (Thrombus)

7/2022

SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lucia Altucci Research Topics

Disease

101	Neoplasms (Cancer) 05/2022 - 05/2002
27	Leukemia 01/2021 - 05/2002
18	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2021 - 02/2004
12	Breast Neoplasms (Breast Cancer) 02/2021 - 04/2003
8	Carcinogenesis 01/2022 - 10/2003
8	Acute Promyelocytic Leukemia 04/2014 - 05/2002
6	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2016 - 09/2009
5	Hypoxia (Hypoxemia) 12/2021 - 01/2014
4	Inflammation (Inflammations) 01/2022 - 01/2020
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2016
4	Colorectal Neoplasms (Colorectal Cancer) 12/2020 - 12/2010
4	Hematologic Neoplasms (Hematological Malignancy) 07/2020 - 09/2010
4	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2017 - 09/2010
3	Carcinoma (Carcinomatosis) 05/2022 - 10/2003
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 09/2012
3	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2014
2	Starvation 05/2022 - 01/2021
2	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 03/2022
2	Ischemia 12/2021 - 03/2019
2	Neuroblastoma 12/2021 - 01/2018
2	Cardiotoxicity 01/2021 - 09/2016
2	Infections 01/2021 - 12/2020
2	Heart Failure 01/2021 - 01/2020
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2019 - 09/2014
2	Neoplasm Metastasis (Metastasis) 01/2019 - 06/2018
2	Liver Neoplasms (Liver Cancer) 10/2018 - 08/2018
2	Mesothelioma 05/2008 - 10/2006
2	Genetic Translocation (Chromosomal Translocation) 02/2004 - 01/2004
1	Thrombosis (Thrombus) 07/2022
1	Methylenetetrahydrofolate reductase deficiency 07/2022
1	Squamous Cell Carcinoma of Head and Neck 05/2022
1	Adenocarcinoma 03/2022

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 05/2022 - 10/2003
24	Histone Deacetylase InhibitorsIBA 01/2021 - 01/2005
13	Pharmaceutical PreparationsIBA 12/2021 - 10/2006
13	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 01/2005
12	ChromatinIBA 03/2021 - 01/2005
11	Biological ProductsIBA 02/2021 - 09/2004
11	Histones (Histone)IBA 12/2019 - 11/2006
10	MicroRNAs (MicroRNA)IBA 12/2020 - 01/2012
10	EnzymesIBA 01/2020 - 05/2009
9	Sirtuin 1IBA 07/2022 - 01/2012
9	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 09/2004
9	SirtuinsIBA 01/2020 - 09/2009
7	Hormones (Hormone)IBA 01/2021 - 04/2003
6	Histone DemethylasesIBA 01/2020 - 01/2014
6	LigandsIBA 04/2015 - 05/2002
6	RetinoidsIBA 04/2014 - 05/2002
6	Estrogens (Estrogen)FDA Link 12/2008 - 12/2003
5	Estrogen Receptor alphaIBA 02/2021 - 08/2004
5	MethyltransferasesIBA 01/2021 - 12/2010
5	Antineoplastic Agents (Antineoplastics)IBA 11/2019 - 07/2012
4	TubulinIBA 05/2022 - 05/2007
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2010
4	Vorinostat FDA Link 05/2019 - 05/2009
4	Histone Acetyltransferases (Histone Acetyltransferase)IBA 09/2014 - 06/2009
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 04/2014 - 05/2002
3	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2020
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2021
3	CaspasesIBA 02/2021 - 01/2007
3	Estrogen ReceptorsIBA 02/2021 - 08/2006
3	CytokinesIBA 01/2021 - 11/2018
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 07/2014
3	Azacitidine (5 Azacytidine)FDA Link 02/2020 - 09/2014
3	Decitabine FDA Link 02/2020 - 09/2014
3	quinolineIBA 02/2020 - 03/2014
3	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 01/2020 - 10/2005
3	Lysine (L-Lysine)FDA Link 12/2019 - 05/2007
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2015 - 10/2005
3	romidepsin (FK228)FDA Link 09/2014 - 09/2010
3	entinostat (MS 275)IBA 07/2014 - 05/2009
3	promyelocytic leukemia-retinoic acid receptor alpha fusion oncoproteinIBA 02/2010 - 05/2002
3	Death Domain ReceptorsIBA 03/2009 - 01/2005
2	domatinostatIBA 04/2022 - 03/2022
2	SodiumIBA 01/2022 - 01/2021
2	Peptides (Polypeptides)IBA 01/2022 - 12/2021
2	AntioxidantsIBA 08/2021 - 05/2013
2	regorafenibIBA 01/2021 - 06/2018
2	Insulin (Novolin)FDA Link 01/2021 - 04/2003
2	VaccinesIBA 01/2021 - 01/2017
2	UbiquitinIBA 07/2020 - 01/2018
2	Proteasome Endopeptidase Complex (Proteasome)IBA 07/2020 - 01/2020
2	Protein Isoforms (Isoforms)IBA 01/2020 - 01/2013
2	MC1568IBA 05/2019 - 12/2008
2	Estradiol (Delestrogen)FDA LinkGeneric 01/2019 - 04/2003
2	bisphenol AIBA 12/2017 - 12/2008
2	Oncogene Proteins (Oncogene Protein)IBA 11/2016 - 01/2005
2	benzamideIBA 01/2015 - 12/2012
2	sirtinolIBA 02/2010 - 04/2008
2	Piroxicam (Feldene)FDA LinkGeneric 05/2008 - 10/2006
2	Cisplatin (Platino)FDA LinkGeneric 05/2008 - 10/2006
2	Retinoic Acid Receptor alphaIBA 10/2005 - 02/2004
1	ResveratrolIBA 07/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022

Therapy/Procedure

41	Therapeutics 05/2022 - 05/2002
9	Drug Therapy (Chemotherapy) 04/2022 - 02/2004
4	Precision Medicine 01/2021 - 01/2017
3	Radiotherapy 01/2021 - 01/2017
2	Immunotherapy 01/2021 - 01/2018
2	Microbubbles 10/2018 - 08/2018